Neurodegeneration-Associated Protein Fragments as Short-Lived Substrates of the N-End Rule Pathway
Brower, Christopher S., Piatkov, Konstantin I., Varshavsky, Alexander
Published in Molecular cell (25.04.2013)
Published in Molecular cell (25.04.2013)
Get full text
Journal Article
Glutamine-Specific N-Terminal Amidase, a Component of the N-End Rule Pathway
Wang, Haiqing, Piatkov, Konstantin I., Brower, Christopher S., Varshavsky, Alexander
Published in Molecular cell (26.06.2009)
Published in Molecular cell (26.06.2009)
Get full text
Journal Article
Formyl-methionine as a degradation signal at the N-termini of bacterial proteins
Piatkov, Konstantin I, Vu, Tri T M, Hwang, Cheol-Sang, Varshavsky, Alexander
Published in Microbial cell (01.10.2015)
Published in Microbial cell (01.10.2015)
Get full text
Journal Article
Liat1, an arginyltransferase-binding protein whose evolution among primates involved changes in the numbers of its 10-residue repeats
Brower, Christopher S., Rosen, Connor E., Jones, Richard H., Wadas, Brandon C., Piatkov, Konstantin I., Varshavsky, Alexander
Published in Proceedings of the National Academy of Sciences - PNAS (18.11.2014)
Published in Proceedings of the National Academy of Sciences - PNAS (18.11.2014)
Get full text
Journal Article
Downregulation of the Arg/N-degron Pathway Sensitizes Cancer Cells to Chemotherapy In Vivo
Leboeuf, Dominique, Abakumova, Tatiana, Prikazchikova, Tatiana, Rhym, Luke, Anderson, Daniel G., Zatsepin, Timofei S., Piatkov, Konstantin I.
Published in Molecular therapy (08.04.2020)
Published in Molecular therapy (08.04.2020)
Get full text
Journal Article
Beta-amyloid induces apoptosis of neuronal cells by inhibition of the Arg/N-end rule pathway proteolytic activity
Kechko, Olga I, Petrushanko, Irina Yu, Brower, Christopher S, Adzhubei, Alexei A, Moskalev, Alexey A, Piatkov, Konstantin I, Mitkevich, Vladimir A, Makarov, Alexander A
Published in Aging (Albany, NY.) (24.08.2019)
Published in Aging (Albany, NY.) (24.08.2019)
Get full text
Journal Article
Abstract 1841: TAK-500 is a clinical stage immune-cell directed antibody drug conjugate (iADC) inducing STING activation in CCR2-expressing intratumor myeloid cells and favorable immunomodulation
Schalper, Kurt A., Matsuda, Atsushi, Ganno-Sherwood, Michelle, Maldonado-Lopez, Angel E., Rosentrater, Emily, Porciuncula, Angelo, Zhang, Dong Mei, Christensen, Camilla L., Merrigan, Samantha A., Hatten, Tiquella, Lee, Hong Myung, Lee, Min Young, Dong, Linlin, Huang, Jian, Iartchouk, Natasha, Wang, Jianing, Xu, He, Yoneyama, Tomoki, Piatkov, Konstantin I., Harbison, Carole E., Parent, Alex, Lineberry, Neil, Abu-Yousif, Adnan O., Appleman, Vicky
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article